- Home
- CNTX vs NTZ Comparison
CNTX vs NTZ Comparison
Compare CNTX & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- NTZ
- Stock Information
- Founded
- CNTX 2015
- NTZ 1959
- Country
- CNTX United States
- NTZ Italy
- Employees
- CNTX N/A
- NTZ N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- NTZ Home Furnishings
- Sector
- CNTX Health Care
- NTZ Consumer Discretionary
- Exchange
- CNTX Nasdaq
- NTZ Nasdaq
- Market Cap
- CNTX 60.7M
- NTZ 52.2M
- IPO Year
- CNTX 2021
- NTZ 1993
- Fundamental
- Price
- CNTX $0.84
- NTZ N/A
- Analyst Decision
- CNTX Strong Buy
- NTZ
- Analyst Count
- CNTX 5
- NTZ 0
- Target Price
- CNTX $6.50
- NTZ N/A
- AVG Volume (30 Days)
- CNTX 257.9K
- NTZ 7.6K
- Earning Date
- CNTX 05-07-2025
- NTZ 04-25-2025
- Dividend Yield
- CNTX N/A
- NTZ N/A
- EPS Growth
- CNTX N/A
- NTZ N/A
- EPS
- CNTX N/A
- NTZ N/A
- Revenue
- CNTX N/A
- NTZ $365,846,531.00
- Revenue This Year
- CNTX N/A
- NTZ N/A
- Revenue Next Year
- CNTX N/A
- NTZ N/A
- P/E Ratio
- CNTX N/A
- NTZ N/A
- Revenue Growth
- CNTX N/A
- NTZ N/A
- 52 Week Low
- CNTX $0.55
- NTZ $3.80
- 52 Week High
- CNTX $2.75
- NTZ $6.43
- Technical
- Relative Strength Index (RSI)
- CNTX 56.99
- NTZ 40.07
- Support Level
- CNTX $0.80
- NTZ $4.01
- Resistance Level
- CNTX $0.89
- NTZ $4.55
- Average True Range (ATR)
- CNTX 0.11
- NTZ 0.50
- MACD
- CNTX 0.03
- NTZ -0.05
- Stochastic Oscillator
- CNTX 73.80
- NTZ 10.37
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.